Emerging drug-resistance infections
Emerging drug-resistance infections
批准号:
7802207
负责人:
LEE W RILEY
金额:
$18.98万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-04 至 2013-03-31
关键词:
AddressAreaBacterial Drug ResistanceBacterial InfectionsBiometryBrazilCaliforniaCommunicable DiseasesComputing MethodologiesData CollectionDatabasesDecision MakingDeveloping CountriesDevelopmentDiseaseDisease OutbreaksDoctor of PhilosophyDrug resistanceEmerging Communicable DiseasesEpidemiologyFacultyFederal GovernmentFutureHospitalsIncomeInfectionInfectious Disease EpidemiologyInservice TrainingIntegronsInternationalInvestigationMediatingMedicineMolecularMolecular BiologyMolecular EpidemiologyNew York CityPlasmidsPolicy MakerPublic HealthPublic Health SchoolsResearchResearch DesignResearch InfrastructureResearch PersonnelResearch TrainingSan FranciscoServicesSiteStructureStudentsTrainingTraining ActivityTraining ProgramsTraining and InfrastructureUniversitiesValidationauthoritybasecommunity settingevidence basegenetic elementmedical schoolsmembermetropolitannosocomial infection controlprogramsresearch studyresistance mechanism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Drug-resistant bacterial infections that occur in both hospital and community settings are an emerging infectious disease problem in large urban centers of middle-income developing countries, such as Brazil. This training program will build on the last 5 years of a training program supported under the Fogarty International Training and Research in Emerging Infectious Diseases (ITREID) to create a sustainable research training infrastructure in Brazil to address the problem of drug-resistant bacterial infections that occur in both hospital and community settings. This infrastructure will be established at the Federal University of Rio de Janeiro (FUR J), involving faculty members at FURJ and in the US who have already been collaborating over the last 5 years. Specifically, the new program will build a training program structured around three areas of research: 1) field epidemiology, 2) molecular epidemiology, and 3) molecular biology of bacterial drug resistance. The training sites in the US will include the Infectious Disease and Epidemiology programs of the School of Public Health at University of California at Berkeley (UCB), the Infectious Disease program at the University of California at San Francisco (UCSF), and Department of Medicine at Weill Medical College of Cornell University in New York City. On-site training at FURJ will be provided for MD, master's and PhD-level students, while a select set of master's, PhD, and postdoctoral students, as well as junior faculty members will be trained short- (3-6 months), intermediate-(6-12 months), or long- (>12 months) term at the US sites. The field epidemiology activities will include on-the-job training in research study design, outbreak investigations, data collection and analyses, disease surveillance, and biostatistics. The molecular epidemiology training will focus on the development, validation, and application of new molecular strain typing methods and computer-based analysis of strain subtyping database to address specific epidemiologic questions. Training in molecular biology of drug-resistance mechanisms will include the analysis of genetic elements (integrons, cassettes, plasmids) that mediate drug resistance. Through these training activities, the program hopes to create a cadre of researchers who will not only become future trainers themselves, but who can generate and provide quality information that will assure evidence-based decision-making by clinicians, nosocomial infection control services, metropolitan public health authorities, and state and national government policy makers in Brazil.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Research Training at the Confluence of Infectious and Non-Communicable Diseases in India
-
批准号:9515095
-
项目类别:
-
资助金额:$21.63万
-
财政年份:2017
-
负责人:LEE W RILEY
-
依托单位:
Research Training at the Confluence of Infectious and Non-Communicable Diseases in India
-
批准号:10012954
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:LEE W RILEY
-
依托单位:
Framework to Address Drug Resistant Infections and Global Health
-
批准号:8051295
-
项目类别:
-
资助金额:$42.53万
-
财政年份:2010
-
负责人:LEE W RILEY
-
依托单位:
In vivo regulation of M. tuberculosis cell wall lipids
-
批准号:7420965
-
项目类别:
-
资助金额:$36.18万
-
财政年份:2009
-
负责人:LEE W RILEY
-
依托单位:
In vivo regulation of M. tuberculosis cell wall lipids
-
批准号:7895606
-
项目类别:
-
资助金额:$37.77万
-
财政年份:2009
-
负责人:LEE W RILEY
-
依托单位:
Therapeutic vaccine against tuberculosis
-
批准号:7086309
-
项目类别:
-
资助金额:$25.98万
-
财政年份:2005
-
负责人:LEE W RILEY
-
依托单位:
Therapeutic vaccine against tuberculosis
-
批准号:6857558
-
项目类别:
-
资助金额:$15.2万
-
财政年份:2005
-
负责人:LEE W RILEY
-
依托单位:
Orgin of multidrug resistant uropathogenic E. coli
-
批准号:6986122
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2004
-
负责人:LEE W RILEY
-
依托单位:
Orgin of multidrug resistant uropathogenic E. coli
-
批准号:7151208
-
项目类别:
-
资助金额:$28.82万
-
财政年份:2004
-
负责人:LEE W RILEY
-
依托单位:
Orgin of multidrug resistant uropathogenic E. coli
-
批准号:7325684
-
项目类别:
-
资助金额:$28.28万
-
财政年份:2004
-
负责人:LEE W RILEY
-
依托单位:
Orgin of multidrug resistant uropathogenic E. coli
-
批准号:6864942
-
项目类别:
-
资助金额:$29.78万
-
财政年份:2004
-
负责人:LEE W RILEY
-
依托单位:
Emerging drug-resistance infections
-
批准号:8051680
-
项目类别:
-
资助金额:$18.98万
-
财政年份:2003
-
负责人:LEE W RILEY
-
依托单位:
Emerging drug-resistant infections
-
批准号:7048697
-
项目类别:
-
资助金额:$14.25万
-
财政年份:2003
-
负责人:LEE W RILEY
-
依托单位:
Emerging drug-resistant infections
-
批准号:7028684
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2003
-
负责人:LEE W RILEY
-
依托单位:
Emerging drug-resistant infections
-
批准号:6701223
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2003
-
负责人:LEE W RILEY
-
依托单位:
Emerging drug-resistant infections
-
批准号:7217962
-
项目类别:
-
资助金额:$13.4万
-
财政年份:2003
-
负责人:LEE W RILEY
-
依托单位:
Emerging drug-resistant infections
-
批准号:6799670
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2003
-
负责人:LEE W RILEY
-
依托单位:
Emerging drug-resistance infections
-
批准号:7668488
-
项目类别:
-
资助金额:$14.01万
-
财政年份:2003
-
负责人:LEE W RILEY
-
依托单位:
Emerging drug-resistance infections
-
批准号:8240438
-
项目类别:
-
资助金额:$18.98万
-
财政年份:2003
-
负责人:LEE W RILEY
-
依托单位:
Epidemiology of an uropathogenic E coli clonal group
-
批准号:6662001
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2002
-
负责人:LEE W RILEY
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: